Physician profile
Steve D Rubinstein
NPI 1528067766
$2,733.57
in general payments reported to CMS, 2019-2025
16 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $201 · 2021: $297 · 2022: $442 · 2023: $354 · 2024: $675 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $717.06 | 2019-2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $440.19 | 2019-2025 | Cequa |
| Rxsight INC | $399.05 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Sight Sciences, INC. | $296.45 | 2022 | |
| Abbvie INC. | $145.63 | 2022 | |
| Astellas Pharma US INC | $125.00 | 2024 | Izervay |
| Horizon Therapeutics Plc | $124.13 | 2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $122.47 | 2021 | |
| Shire North American Group INC | $111.05 | 2019 | |
| Visioneering Technologies, INC. | $69.60 | 2019 | |
| Alcon Vision LLC | $63.79 | 2020-2021 | |
| Amgen INC. | $55.46 | 2024 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.58 | 2020 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Alcon Research LLC | $14.61 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.